SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (2809)2/8/2007 6:16:52 PM
From: Mike K  Read Replies (1) of 3044
 
Hi Rick;

I'm doing very well. It's 10 years since my myeloma
diagnosis. I was fortunate to have over 5 years in
remission following tandem stem cell transplants.
I relapsed late last fall and started Revlimid + Decadron.

So far the results have been great! And yes, my reason
for choosing Revlimid over Velcade was the convenience
of a daily oral drug versus a visit to the doctor's office
for twice a week injections.

That said, I know many patients on Velcade who are having
equally positive results.

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News